Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Banner Pharmacaps Receives FDA Approval for Nimodipine Softgel Capsules.


HIGH POINT, N.C. -- Banner Pharmacaps Inc., a leader in the pharmaceutical industry for the development of soft gelatin gelatin or animal jelly, foodstuff obtained from connective tissue (found in hoofs, bones, tendons, ligaments, and cartilage) of vertebrate animals by the action of boiling water or dilute acid.  dosage form technology, today announced that the US Food & Drug Administration has granted approval for the Company's Abbreviated New Drug Application abbreviated new drug application Pharmacology An application made in the US by a pharmaceutical company requesting authority to market a 'new' drug for which both its therapeutic indications and formulation were previously approved by the FDA in another similar  (ANDA ANDA
abbr.
abbreviated new drug application
) for Nimodipine 30 mg soft gelatin capsules.

Banner's Nimodipine 30 mg capsules are the AB-rated generic equivalent of Bayer's Nimotop[R] 30 mg capsules, and are indicated for the treatment of subarachnoid hemorrhage, a form of cerebral bleed. Banner's product can be dispensed either in blister packaging or in bottles.

Banner has partnered with Heritage Pharmaceuticals Inc., an Edison, New Jersey Edison Township (usually known as Edison) is a township in Middlesex County, New Jersey, United States. As of the United States 2000 Census, the township had a total population of 97,687, making it at the time the fifth largest municipality in New Jersey. As of the U.S.  based generics company, for the exclusive US sales and marketing rights for Nimodipine.

About Banner Pharmacaps Inc.

Banner Pharmacaps Inc. is a global drug delivery and specialty pharmaceutical company which is developing a proprietary portfolio of unique products and oral dosage forms that include the enhanced technologies of enteric and controlled release softgels, as well as Soflet[R] Gelcaps. Headquartered in High Point, North Carolina
For other places named High Point, see High Point (disambiguation).


High Point is a city located in the Piedmont Triad region of North Carolina -- the 36th largest metro area in the United States with a population of 1.5 million.
, Banner is committed to the research, development, and manufacture of quality healthcare products to serve our global community. Additional information about Banner is available at http://www.banpharm.com.

The parent company of Banner is VION N.V., an international food group that produces high-quality foodstuffs foodstuffs nplcomestibles mpl

foodstuffs npldenrées fpl alimentaires

foodstuffs food npl
 and ingredients for humans and animals. VION has annual sales of EU7.4 Billion, with 15,150 employees worldwide. The head office of VION is in Son en Breugel Son en Breugel ( (helpinfo)) is a municipality in the southern Netherlands just outside of Eindhoven. 15,204 lived in this municipality as of June 1, 2005. Son en Breugel is 26,67 km² (of which 0,28 km² water). , The Netherlands.

About Heritage Pharmaceuticals

Heritage Pharmaceuticals Inc. is an emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its U.S. label in 2006 and currently markets 4 products over 15 SKU's. The Company will continue to introduce its acquired multi-source generic product line during 2008 following its tradition of premier quality, value and service in generics. The Heritage website is http://www.heritagepharma.com.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 23, 2008
Words:325
Previous Article:TenFold Announces Reduction in Workforce.
Next Article:Standard & Poor's Initiates Factual Stock Report Coverage on NAL Oil & Gas Trust.
Topics:



Related Articles
Eon Labs receives FDA approval to market generic equivalent to Novartis Neoral.
Eon Labs, Mylan Pharmaceuticals enter agreement to co-promote generic cyclosporine softgel capsules to hospitals.
Seatrace's 'exceptions' to validation wind up on 483.
FDA inspects R.P. Scherer seven times in three years.
Sandoz plagued by slips in stability, failure probes.
FDA hits top managers at Banner, citing inaction.
Blood/Biologics. (Food and Drug Administration's Team Biologics' reports on inspected pharmaceutical companies).
Banner Pharmacaps conference held.
Banner fails to follow stability program in 6-item 483.
FDA GIVES TENTATIVE APPROVAL OF STAVZOR.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles